EUVIMEDDescoperă EUVIMED
Open access · CC BY 4.0

Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China

Tongling Xie, Jingyi Meng, Zhe Feng, Yue Gao, Tian Chen, Yalan Chen iD, Jinsong Geng iD

Health Expectations · 2024

DOI: 10.1111/hex.14059 ↗

At a glance

Journal article in Health Expectations, 2024. Written by Tongling Xie and 6 co-authors. Institution: Center for Evidence-Based Medicine, Nantong University Medical School, Nantong, China. Major MEDLINE topics: Hypoglycemic Agents, Diabetes Mellitus, Type 2, Decision Making, Shared. Cited 4 times so far (Crossref); 53 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, MOE (Ministry of Education in China) Project of Humanities and Social Sciences.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

Shared decision‐making (SDM) is a patient‐centred approach to improve the quality of care. An essential requirement for the SDM process is to be fully aware of patient information needs.

Objectives

Our study aimed to assess patient information needs for new antidiabetic medications using the best–worst scaling (BWS) experiment.

Methods

BWS tasks were developed according to a literature review and the focus group discussion. We used a balanced incomplete block design and blocking techniques to generate choice sets. The final BWS contains 11 attributes, with 6‐choice scenarios in each block. The one‐to‐one, face‐to‐face BWS survey was conducted among type 2 diabetic patients in Jiangsu Province. Results were analyzed using count‐based analysis and modelling approaches. We also conducted a subgroup analysis to observe preference heterogeneity.

Results

Data from 539 patients were available for analysis. The most desired information domain was the comparative effectiveness of new antidiabetic medications. It consists of the incidence of macrovascular complications, the length of extended life years, changes in health‐related quality of life, the incidence of microvascular complications, and the control of glycated haemoglobin. Of all the attributes, the incidence of macrovascular complications was the primary concern. Patients' glycemic control and whether they had diabetes complications exerted a significant influence on their information needs.

Conclusions

Information on health benefits is of critical significance for diabetic patients. Patients have different information needs as their disease progresses. Personalized patient decision aids that integrate patient information needs and provide evidence of new antidiabetic medications are worthy of being established. Patient or Public Contribution Before data collection, a pilot survey was carried out among diabetic patients to provide feedback on the acceptability and intelligibility of the attributes.

Subjects

MeSH terms (MEDLINE)

Hypoglycemic AgentsDiabetes Mellitus, Type 2Decision Making, SharedHumansChinaMaleMiddle AgedFemaleFocus GroupsAgedSurveys and QuestionnairesNeeds AssessmentPatient ParticipationAdult

Author keywords

best–worst scalingdiabetesinformation needsshared decision‐making

Substances

Hypoglycemic Agents

Authors and institutions

  • Center for Evidence-Based Medicine, Nantong University Medical School, Nantong, China.
  • Information Center, The People's Hospital of Rugao, Nantong, China.
  • Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Department of Rehabilitation Medicine and Clinical Medicine, Medical Institute of Taizhou Polytechnic College, Taizhou, China.

ORCID profiles: Yalan Chen, Jinsong Geng

Funding

  • National Natural Science Foundation of China
  • MOE (Ministry of Education in China) Project of Humanities and Social Sciences

Cite

APA

Xie, T., Meng, J., Feng, Z., Gao, Y., Chen, T., Chen, Y., & Geng, J. (2024). Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China. Health Expectations. https://doi.org/10.1111/hex.14059

Vancouver

Xie T, Meng J, Feng Z, Gao Y, Chen T, Chen Y, et al. Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China. Health Expectations. 2024. doi:10.1111/hex.14059

BibTeX
@article{Xie2024,
  author = {Xie, Tongling and Meng, Jingyi and Feng, Zhe and Gao, Yue and Chen, Tian and Chen, Yalan and Geng, Jinsong},
  title = {Assessing patient information needs for new antidiabetic medications to inform shared decision‐making: A best–worst scaling experiment in China},
  journal = {Health Expectations},
  year = {2024},
  doi = {10.1111/hex.14059}
}
Start for free →